IOVS Journal of Clinical Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Tripathi, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Tripathi, R. C.
(Investigative Ophthalmology and Visual Science. 2000;41:3437-3443.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Modulation of Pre-mRNA Splicing and Protein Production of Fibronectin by TGF-ß2 in Porcine Trabecular Cells

Junping Li1, Brenda J. Tripathi1,2 and Ramesh C. Tripathi1,2

1 From the Departments of Ophthalmology and 2 Pathology, University of South Carolina School of Medicine, Columbia.

PURPOSE. To determine the effect of transforming growth factor (TGF)-ß2 on the pre-mRNA splicing pattern of fibronectin, as well as on the synthesis and secretion of this glycoprotein by porcine trabecular cells.

METHODS. First-passage porcine trabecular cells were rendered quiescent and incubated in culture medium containing 15% newborn calf serum, in serum-free culture medium containing either activated TGF-ß2 (concentration range: 0.2–2.7 ng/ml) or activated TGF-ß1 (1 ng/ml), or in serum-free medium alone (untreated control samples). For investigation of alternative splicing, total RNA was extracted, and reverse transcription–polymerase chain reaction (RT-PCR) was performed with primer pairs located in exons flanking the exon (extra domain [ED]A, or EDB) that undergoes alternative splicing. The polymerase chain reaction (PCR) products were verified by Southern hybridization and quantified by using laser densitometry. The percentage of EDA-positive (+) isoforms was compared with that of the EDB+ isoforms among the groups. To study the effect of TGF-ß2 on the synthesis and secretion of fibronectin, total protein was extracted from both cultured cells and conditioned medium, Western blot analysis was performed using an anti-fibronectin antibody, and the products were quantified by laser densitometry. Immunocytochemical analysis was also performed on cultured trabecular cells to detect fibronectin.

RESULTS. Fibronectin mRNA that was detected in untreated serum-starved control cells was EDA and EDB negative. Incubation of trabecular cells in medium containing 1 ng/ml TGF-ß2, 1 ng/ml TGF-ß1, or 15% newborn calf serum induced the expression of EDA+ and EDB+ mRNA to varying degrees. At concentrations of 0.2, 0.5, 1.5, and 2.7 ng/ml, TGF-ß2 increased the concentration of fibronectin by 2-, 3-, 3.8-, and 5-fold in the conditioned medium, and by 3-, 3.7-, 4-, and 4.3-fold in the cell extracts, respectively. The trabecular cells treated with TGF-ß2 exhibited strong immunoreaction for fibronectin, whereas the cells incubated in serum-free medium showed only minimal immunoreactivity.

CONCLUSIONS. Our results demonstrate that TGF-ß2 and TGF-ß1 modified the alternative splicing pattern of fibronectin pre-mRNA and enhanced the synthesis and secretion of this extracellular matrix molecule by trabecular cells in a dose-dependent fashion. These findings indicate a mechanism whereby TGF-ß2, the concentration of which is elevated in aqueous humor of patients with primary open-angle glaucoma, contributes to the increased deposition of extracellular matrix molecules in the outflow pathway.




This article has been cited by other articles:


Home page
IOVSHome page
R. Fuchshofer, A. H. L. Yu, U. Welge-Lussen, and E. R. Tamm
Bone Morphogenetic Protein-7 Is an Antagonist of Transforming Growth Factor-{beta}2 in Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 715 - 726.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. L. Fleenor, A. R. Shepard, P. E. Hellberg, N. Jacobson, I.-H. Pang, and A. F. Clark
TGF{beta}2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 226 - 234.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. Vittal, A. Rose, K. E. Gregory, M. J. Kelley, and T. S. Acott
Changes in Gene Expression by Trabecular Meshwork Cells in Response to Mechanical Stretching
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2857 - 2868.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Santas, C. Bahler, J. A. Peterson, M. S. Filla, P. L. Kaufman, E. R. Tamm, D. H. Johnson, and D. M. P. Peters
Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4796 - 4804.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Nakamura, T. Sagara, K. Seki, S. Hirano, and T. Nishida
Permissive Effect of Fibronectin on Collagen Gel Contraction Mediated by Bovine Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4331 - 4336.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. K. Wirtz, J. R. Samples, H. Xu, T. Severson, and T. S. Acott
Expression Profile and Genome Location of cDNA Clones from an Infant Human Trabecular Meshwork Cell Library
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3698 - 3704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology